Chargement en cours...
Bevacizumab in combination with chemotherapy for the treatment of advanced ovarian cancer: a systematic review
As increased angiogenesis has been linked with the progression of ovarian cancer, a number of anti-angiogenic agents have been investigated, or are currently in development, as potential treatment options for patients with advanced disease. Bevacizumab, a recombinant monoclonal antibody against vasc...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BioMed Central
2014
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4033616/ https://ncbi.nlm.nih.gov/pubmed/24864163 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1757-2215-7-57 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|